Get started
Author

Pradip Nair

Immunogenicity of Biotherapeutics: Causes and Association with Posttranslational Modifications
2016 · Anshu Kuriakose, Narendra Chirmule, et al. · Journal of Immunology Research · 240
PDF
Activated Notch1 Inhibits p53-Induced Apoptosis and Sustains Transformation by Human Papillomavirus Type 16 E6 and E7 Oncogenes through a PI3K-PKB/Akt-Dependent Pathway
2003 · Pradip Nair, Kumaravel Somasundaram, et al. · Journal of Virology · 169
Efficacy and safety of itolizumab, a novel anti-CD6 monoclonal antibody, in patients with moderate to severe chronic plaque psoriasis: Results of a double-blind, randomized, placebo-controlled, phase-III study
2014 · D.S. Krupashankar, Sunil Dogra, et al. · Journal of the American Academy of Dermatology · 105
Deciphering T-cell exhaustion in the tumor microenvironment: paving the way for innovative solid tumor therapies
2025 · Reshmi Nair, Veena Somasundaram, et al. · Frontiers in Immunology · 100
PDF
Coexpression of Notch1 and NF-κB signaling pathway components in human cervical cancer progression
2006 · Bharathi Ramdass, Tessy T. Maliekal, et al. · Gynecologic Oncology · 88
CD6 synergistic co-stimulation promoting proinflammatory response is modulated without interfering with the activated leucocyte cell adhesion molecule interaction
2010 · P Nair, R Melarkode, et al. · Clinical & Experimental Immunology · 72
Nimotuzumab with chemoradiation confers a survival advantage in treatment-naïve head and neck tumors over expressing EGFR
2010 · Chetana Basavaraj, Patricia Sierra, et al. · Cancer Biology & Therapy · 71
PDF
T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab
2017 · Usha Bughani, Arindam Saha, et al. · PLoS ONE · 55
Papillomavirus-Mediated Neoplastic Progression Is Associated with Reciprocal Changes in Jagged1 and Manic Fringe Expression Linked to Notch Activation
2004 · Karthikeyan Veeraraghavalu, Mark Pett, et al. · Journal of Virology · 46
Cellular manifestations of human papillomavirus infection in the oral mucosa
1999 · M. Radhakrishna Pillai, A. Phanidhara, et al. · Journal of Surgical Oncology · 41
BCA101 Is a Tumor-Targeted Bifunctional Fusion Antibody That Simultaneously Inhibits EGFR and TGFβ Signaling to Durably Suppress Tumor Growth
2023 · Srinivas Reddy Boreddy, Reshmi Nair, et al. · Cancer Research · 40
PDF
Epidermal growth factor receptor family and its role in cancer progression
2005 · Pradip Nair · 40
Telomerase, p53 and Human Papillomavirus Infection in the Uterine Cervix
2000 · Pradip Nair · Acta Oncologica · 25
PDF
Spontaneous Programmed Cell Death in Infiltrating Duct Carcinoma: Association with p53, BCL-2, Hormone Receptors and Tumor Proliferation
1998 · M. Radhakrishna Pillai, A. Lakshmi Kesari, et al. · Pathology - Research and Practice · 20
Increased Angiogenesis in the Uterine Cervix Associated with Human Papillomavirus Infection
1999 · Pradip Nair, T. Gangadevi, et al. · Pathology - Research and Practice · 18
Safety, Efficacy and pharmacokinetics of T1h, a humanized anti-CD6 monoclonal antibody, in moderate to severe chronic plaque psoriasis - Results from a randomized phase II trial. (96.13)
2010 · Arun Anand, Deepak Assudani, et al. · The Journal of Immunology · 17
p53 tumor suppressor protein and tissue proliferative fraction in infiltrating duct carcinoma
1997 · A. Lakshmi Kesari, V. G. Chellam, et al. · Journal of Surgical Oncology · 10
Tumor proliferative fraction in infiltrating duct carcinoma.
1997 · A L Kesari, V G Chellam, et al. · PubMed · 9
Expression of the Antiapoptotic Protein bcl-2 Is Not Dependent on the Tumor Suppressor p53 Protein in Indian Breast Carcinoma
2008 · Lakshmi Kesari, V.G. Chellam, et al. · Pathobiology · 8
Biomarkers
2025 · Pradip Nair, O. S. Bindhu, et al. · Springer eBooks · 5
Analytical similarity assessment of MYL-1402O to reference Bevacizumab
2021 · Parag Goyal, Bhavesh Vats, et al. · Expert Opinion on Biological Therapy · 5
EGFR targeting monoclonal antibody combines with an mTOR inhibitor and potentiates tumor inhibition by acting on complementary signaling hubs
2012 · Roshan James, Siddharth Vishwakarma, et al. · Cancer Medicine · 4
PDF
874 Development of BCA101, a bifunctional antibody capable of simultaneously disabling EGFR and TGFβ signaling, as novel single-agent immunotherapy
2021 · Srinivas Reddy Boreddy, Reshmi Nair, et al. · Journal for ImmunoTherapy of Cancer · 3
PDF
Correction: T cell activation and differentiation is modulated by a CD6 domain 1 antibody Itolizumab
2018 · Usha Bughani, Arindam Saha, et al. · PLoS ONE · 3
PDF
The inhibition of T cell proliferation in a mixed lymphocyte reaction by Itolizumab (T1h) is associated with reduction in pro inflammatory cytokines and CD6 internalization. (52.27)
2011 · Pradip Nair, Abhijit Ghorai, et al. · The Journal of Immunology · 3
Works count: 44
Citation count: 1,204
H-index: 16
I10-index: 17
Year
Topic
Type